Has Raluca Ioanid received payments from drug or device companies?

Yes. Drug and device makers reported $4,835 in general payments to Raluca Ioanid across 159 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raluca Ioanid did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raluca Ioanid come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raluca Ioanid

Family · Santa Cruz, CANPI 1831479054

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.8% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 55 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,473, more than ten times the $228 reported in 2023. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,835in general payments, 2019–2025

Across 159 payments — averaging $30.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$522
Johnson & Johnson$341
Merck$292
Astellas Pharma US Inc$235
Genentech USA, Inc.$179
Boehringer Ingelheim$175
plus $3K from 49 others

What the payments were for

Food & beverage$4,43792%
Education$3988%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	15	$522
Johnson & Johnson	11	$341
Merck	10	$292
Astellas Pharma US Inc	6	$235
Genentech USA, Inc.	6	$179
Boehringer Ingelheim	3	$175
Jazz Pharmaceuticals Inc.	4	$155
Array Biopharma Inc	5	$147
Daiichi Sankyo Inc.	6	$147
Takeda Pharmaceuticals U.S.A., Inc.	4	$147
Incyte Corporation	5	$127
AVEO Pharmaceuticals, Inc.	2	$120
Novartis	4	$113
Pfizer	4	$108
Stemline Therapeutics Inc.	3	$106
Agios Pharmaceuticals, Inc.	3	$98
Lilly USA, LLC	3	$93
Genmab U.S., Inc.	3	$89
Gilead(2 entities)	4	$84
Regeneron Healthcare Solutions, Inc.	3	$72
Taiho Oncology, Inc.	2	$71
Octapharma USA, Inc.	2	$68
Deciphera Pharmaceuticals Inc.	2	$68
Eisai Inc.	2	$64
Caris MPI, Inc.	2	$63
Coherus Oncology, Inc.	2	$63
Bayer	3	$62
Karyopharm Therapeutics Inc.	2	$60
Geron Corporation	2	$54
Abbott	1	$54
Kyowa Kirin, Inc.	2	$52
Myriad Genetic Laboratories, Inc.	1	$51
Exelixis Inc.	1	$46
Bristol Myers Squibb	2	$46
Novocure Inc.	3	$45
Blueprint Medicines Corporation	1	$44
Rigel Pharmaceuticals, Inc.	2	$44
Accord Healthcare, Inc.	2	$43
Spectrum Pharmaceuticals Inc.	1	$43
Servier Pharmaceuticals LLC	2	$41
Legend Biotech USA Inc.	2	$37
Biocon Biologics Inc	2	$35
Beone Medicines USA, Inc.	1	$31
GSK	2	$31
Immunocore Limited	1	$29
EMD Serono, Inc.	1	$29
Iovance Biotherapeutics, Inc.	1	$28
AbbVie	1	$27
Sobi, Inc	1	$25
ADC Therapeutics America, Inc.	1	$23
Acrotech Biopharma Inc.	1	$22
Tersera Therapeutics LLC	1	$22
E.r. Squibb & Sons, L.L.C.	1	$21
Puma Biotechnology, Inc.	1	$21
Sun Pharmaceutical Industries Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,835 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	11	$857
Albuterol Sulfate HfaAlbuterol Sulfate	21	$547
Gabapentin	21	$300
Levothyroxine Sodium	39	$246
Fenofibrate	11	$172
Atorvastatin Calcium	31	$101
Omeprazole	27	$71
Losartan Potassium	11	$53
Spironolactone	12	$49
Lisinopril	11	$46
Furosemide	13	$26
Amlodipine Besylate	20	$15

Paid to pharmacies, not to this prescriber.

Other family in Santa Cruz

Lori RobertsonChino Hills$475K
Annette ShonLos Angeles$406K
Lisa HigginsHanford$311K
Jennifer TougasBakersfield$302K
Kim SchaferSacramento$288K
Dawn MeyerSan Diego$270K
Jennifer KangCerritos$255K
Erin DwyerSan Diego$189K
Phyllis CasonLos Angeles$187K
Gabriel SchwartzSan Francisco$166K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →